BEAT-PCD annual meeting 2021 - Agenda:
13:00 - Welcome, meeting rules and introduction
Amelia Shoemark and Myrona Goutaki
13:15 - Work package summaries (10 min each including questions)
Work Package Leads
14:15 - 30 minute break/interactive sessions
14:45 - PCD genetics and molecular therapies (3x10 min talks including questions)
Chairs: Heymut Omran and Mathieu Bottier
Development and first results of the BEAT-PCD international Primary Ciliary Dyskinesia gene variant database: CiliaVar - Amelia Shoemark
High-content screening for rare respiratory diseases: read through therapy in primary ciliary dyskinesia - Chris O'Callaghan
A messenger RNA (mRNA)-based therapeutic designed o treat PCD - Caroline Woo
15:15 - Genome-wide analysis of PCD gene variant frequencies: estimated prevalence and
ethnic heterogeneity (15 min, 5 min questions) - Will Hannah
15:35 - Cohort studies on PCD (2 x 10 min talks including questions)
Chairs: Claudia Kuehni and Renate Kos
The EPIC-PCD study: time to focus on the upper airways - Myrona Goutaki
COVID-PCD: results and future plans - Eva Pedersen
15:55 - Highlights from the ERS meeting (5 x 10 min talks including questions)
Chairs: Jane Lucas and Rob Hirst
The short term influence of chest physiotherapy on lung function parameters in pediatric bronchiectasis - Mieke Boon
The international primary ciliary dyskinesia (PCD) registry reports genotype/phenotype correlations - Johanna Raidt
Service delivery models for primary ciliary dyskinesia, an international comparison - Bruna Rubbo
Diagnosis of Primary Ciliary Dyskinesia: Discrepancy according to different algorithms - Mirjam Nussbaumer
The prevalence of primary ciliary dyskinesia (PCD) in adult patients with bronchiectasis in Dnipro (Ukraine) - Kseniia Suska
16.45 - Closing Remarks
Amelia Shoemark and Myrona Goutaki
17:00 - Break out meetings for specific projects (until 17:30-17:45)
Register here.
